Hemophilia gene therapy: first, do no harm

This publication has 88 references indexed in Scilit:

• Personalized prophylaxis
  Haemophilia, 2012
• Shared Decision Making — The Pinnacle of Patient-Centered Care
  New England Journal of Medicine, 2012
• Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia
  Molecular Therapy, 2011
• Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials
  Haemophilia, 2011
• Athletic Participation in Severe Hemophilia: Bleeding and Joint Outcomes in Children on Prophylaxis
  Pediatrics, 2009
• Social participation of patients with hemophilia in the Netherlands
  Blood, 2008
• Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV
  Blood, 2007
• Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment
  Journal of Thrombosis and Haemostasis, 2007
• Life expectancy in hemophilia outcome
  Journal of Thrombosis and Haemostasis, 2006
• The Hemophilias — From Royal Genes to Gene Therapy
  New England Journal of Medicine, 2001